title: Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
authors.affiliation: Department of Hematology.
authors.forename: Laura
authors.initials: L
authors.lastname: Magnano
authors.affiliation: Department of Autoimmune Diseases;
authors.forename: Hector
authors.initials: H
authors.lastname: Enríquez
authors.affiliation: Department of Hematology.
authors.forename: Jordi
authors.initials: J
authors.lastname: Esteve
authors.affiliation: Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain.
authors.forename: Ricard
authors.initials: R
authors.lastname: Cervera
authors.affiliation: Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain. gespino@clinic.ub.es.
authors.forename: Gerard
authors.initials: G
authors.lastname: Espinosa
mesh_terms: D000328:Adult; D000368:Aged; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag